AsiaIntervention (@asiainterv) 's Twitter Profile
AsiaIntervention

@asiainterv

AsiaIntervention is the official journal of the Asian-Pacific Society of Interventional Cardiology @APSIC6 and the Interventional Cardiology Foundation of India

ID: 3365878841

linkhttp://www.asiaintervention.org/ calendar_today08-07-2015 12:43:45

209 Tweet

546 Followers

58 Following

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

🎥In this interview, Valeria Paradies and Chiara De Biase discuss the new expert consensus document on sex-specific risks, tailored antithrombotic strategies, and improving female representation in ACS trials published in EuroIntervention with the #EAPCI and the European Society of Cardiology working group

AsiaIntervention (@asiainterv) 's Twitter Profile Photo

AsiaIntervention held its 2025 Strategic Board Meeting at EuroPCR in Paris with Editor-in-Chief Upendra Kaul and Deputy Editors. Grateful for their inspiring leadership. #EuroPCR #interventionalcardiology

AsiaIntervention held its 2025 Strategic Board Meeting at EuroPCR in Paris with Editor-in-Chief Upendra Kaul and Deputy Editors. Grateful for their inspiring leadership. #EuroPCR #interventionalcardiology
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

#EuroPCR - PCR Perspectives: How to implement the diagnosis of #INOCA in everyday practice 📺pcronline.com/Cases-resource… Professor Vijay Kunadian and Javier Escaned explore the real-world implementation of INOCA (#Ischemia with Non-Obstructive Coronary Arteries) and #ANOCA (Angina with

AsiaIntervention (@asiainterv) 's Twitter Profile Photo

🚀 Steerable microcatheter aids complex CTO PCI in LCx with severe tortuosity. Game-changer for tough anatomies! 💡🫀 🔗 Full study: asiaintervention.org/article/recana… #PCI #CTO #Cardiology #Innovation #MedicalDevices #Intervention

🚀 Steerable microcatheter aids complex CTO PCI in LCx with severe tortuosity. Game-changer for tough anatomies! 💡🫀

🔗 Full study:
asiaintervention.org/article/recana…

#PCI #CTO #Cardiology #Innovation #MedicalDevices #Intervention
Salvatore Brugaletta (@sbrugaletta) 's Twitter Profile Photo

My learning points from #euroPCR 2025: #IC community interests are high in the coronary field despite growing of the structural field. Topics which surprised me in terms of assistance are vulnerable plaque, coronary thrombectomy, imaging, physiology and CHIP.this reflects the

My learning points from #euroPCR 2025: #IC community interests are high in the coronary field despite growing of the structural field. Topics which surprised me in terms of assistance are vulnerable plaque, coronary thrombectomy, imaging, physiology and CHIP.this reflects the
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

PCR Perspectives: how to manage treatment dilemmas in #STEMI patients with multivessel disease 📺pcronline.com/Cases-resource… Managing STEMI patients with MVD is a complex challenge evolving rapidly thanks to new clinical evidence. Angela McInerney , Natalia Pinilla, and Matthias Götberg

PCR Perspectives: how to manage treatment dilemmas in #STEMI patients with multivessel disease

📺pcronline.com/Cases-resource…

Managing STEMI patients with MVD is a complex challenge evolving rapidly thanks to new clinical evidence. <a href="/McInerneyAngela/">Angela McInerney</a> , <a href="/DrNataliaP/">Natalia Pinilla</a>, and <a href="/MGtberg/">Matthias Götberg</a>
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

61-year-old with recurrent stent blockage treated with #cuttingballoons and #drugelutingtech. #OCT showed success—and paclitaxel crystals. Symptom-free at 4 months! 💉🫀📈 #InterventionalCardiology Read the full article on AsiaIntervention: asiaintervention.org/article/paclit…

61-year-old with recurrent stent blockage treated with #cuttingballoons and #drugelutingtech. #OCT showed success—and paclitaxel crystals. Symptom-free at 4 months! 💉🫀📈 #InterventionalCardiology

Read the full article on AsiaIntervention: 
asiaintervention.org/article/paclit…
Yael L. Maxwell (@tctmd_yael) 's Twitter Profile Photo

At #EuroPCR, I sat down with EuroIntervention EIC Davide Capodanno for TCTMD's #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine. tctmd.com/videos/on-reco…

At #EuroPCR, I sat down with <a href="/EuroInterventio/">EuroIntervention</a> EIC <a href="/DFCapodanno/">Davide Capodanno</a> for <a href="/TCTMD/">TCTMD</a>'s #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine.

tctmd.com/videos/on-reco…
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

80F with LMT/LAD blockage had #PCI. #OCT showed a Z-shaped catheter risking fracture. Using the newer #Opstardevice avoided this. Device design is crucial in #patientsafety. Read more here: asiaintervention.org/article/optica… @APSIC EuroIntervention PCRonline 🫀

80F with LMT/LAD blockage had #PCI. #OCT showed a Z-shaped catheter risking fracture. Using the newer #Opstardevice avoided this. Device design is crucial in #patientsafety. 

Read more here:
asiaintervention.org/article/optica…

<a href="/APSIC6/">@APSIC</a> <a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a>
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

🚨 A new heart valve system just passed its first human test! The Crea Valve showed strong results with no major complications. A big step forward for heart care! 🫀 #HeartHealth #MEDTECH @APSIC EuroIntervention PCRonline 🫀 Read more: asiaintervention.org/article/initia…

🚨 A new heart valve system just passed its first human test! The Crea Valve showed strong results with no major complications. A big step forward for heart care! 🫀 
#HeartHealth #MEDTECH 
<a href="/APSIC6/">@APSIC</a> <a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a> 

Read more: asiaintervention.org/article/initia…
Novi Yanti Sari (@slumberbell) 's Twitter Profile Photo

#ICI myocarditis, could we rechallenge?🫀 ⚠️#Multidisciplinary team discussion is 🔑key before deciding on rechallenge 🆚 permanent discontinuation Considerations include: 📍Clinical presentation: is it fulminant, non-fulminant, or asymptomatic? 📍Alternative cancer treatments

#ICI myocarditis, could we rechallenge?🫀

⚠️#Multidisciplinary team discussion is 🔑key before deciding on rechallenge 🆚 permanent discontinuation

Considerations include:
📍Clinical presentation: is it fulminant, non-fulminant, or asymptomatic?
📍Alternative cancer treatments
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

Even #BASILICA can’t always prevent coronary occlusion during #TAVI—especially with valve misalignment. A must-read case for structural heart teams. 🫀 👉 asiaintervention.org/article/commis… @APSIC EuroIntervention PCRonline 🫀

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

Next-day discharge after alternative access #TAVI? In this prospective study of 85 A-TAVI patients, NDD/48h discharge was safe with low 30-day readmission and zero mortality. Transapical access required longer stay, but ~50% discharged by day 2. Rodrigo Bagur 🇦🇷🇨🇦

Next-day discharge after alternative access #TAVI? 
In this prospective study of 85 A-TAVI patients, NDD/48h discharge was safe with low 30-day readmission and zero mortality. Transapical access required longer stay, but ~50% discharged by day 2.  <a href="/RodrigoBagur/">Rodrigo Bagur 🇦🇷🇨🇦</a>
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

First #Cardiovalve tricuspid valve replacement in Asia! 🫀 A game-changer for high-risk #heartfailure patients. 👉 asiaintervention.org/article/transc… @APSIC EuroIntervention PCRonline 🫀

First #Cardiovalve tricuspid valve replacement in Asia! 🫀 A game-changer for high-risk #heartfailure patients. 
👉 asiaintervention.org/article/transc… 

<a href="/APSIC6/">@APSIC</a> <a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a>
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

Successful #percutaneousclosure of a perimembranous ventricular septal defect (pmVSD) in a 2-month-old infant using the #AmplatzerDuctOccluderII device. #PediatricCardiology 👉asiaintervention.org/article/percut… @APSIC EuroIntervention PCRonline 🫀

Successful #percutaneousclosure of a perimembranous ventricular septal defect (pmVSD) in a 2-month-old infant using the #AmplatzerDuctOccluderII device. #PediatricCardiology 
👉asiaintervention.org/article/percut…

<a href="/APSIC6/">@APSIC</a> <a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a>
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

🚨 3-yr data: BioMime Morph SES shows 98.8% TLF-free survival, 0.24% ST, 0.5% mortality in very long lesions (50–60 mm). No overlaps. No IVUS. Strong real-world outcomes. 📄asiaintervention.org/article/long-t… @APSIC EuroIntervention PCRonline 🫀

🚨 3-yr data: BioMime Morph SES shows 98.8% TLF-free survival, 0.24% ST, 0.5% mortality in very long lesions (50–60 mm). No overlaps. No IVUS. Strong real-world outcomes.
📄asiaintervention.org/article/long-t…
<a href="/APSIC6/">@APSIC</a> <a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a>
AsiaIntervention (@asiainterv) 's Twitter Profile Photo

Promising results with #MeRes100 bioresorbable scaffold: 98.84% success, 0% thrombosis, MI, or TLR at 12 months. A metal-free future for PCI? 📖asiaintervention.org/article/a-real… @APSIC EuroIntervention PCRonline 🫀

Promising results with #MeRes100 bioresorbable scaffold: 98.84% success, 0% thrombosis, MI, or TLR at 12 months. A metal-free future for PCI? 
📖asiaintervention.org/article/a-real…

<a href="/APSIC6/">@APSIC</a> <a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a>